YURiA-PHARM Adopts LifeSphere® Regulatory
The Ukrainian pharmaceutical company modernizes regulatory operations with a centralized platform and multi-phase innovation strategy.
Global Biopharmaceutical Company Goes Live with LifeSphere® NavaX in Japan
The latest deployment further highlights the momentum around production AI-driven NavaX implementations, and showcases the platform’s readiness for complex, character-based languages.
ArisGlobal Accelerates Growth and AI Adoption Following Strong 2025 Performance
More than 100 new and expanded LifeSphere customers, 34 global go-lives, and rapid enterprise adoption of NavaX signal strong momentum
ArisGlobal Announces Breakthrough 2026 Speaker LineupÂ
More than 50 executive speakers and 300 life sciences professionals ...
Another Top Global Pharmaceutical Organization Goes Live with LifeSphere® NavaX™
Company leverages Generative AI across case management processes, achieving ...
ArisGlobal Announces NavaXâ„¢ Agents Suite
Orchestrated by the NavaX Super Agent, the Suite includes previously ...
Nippon Shinyaku Selects LifeSphere® Safety
Japan-based Nippon Shinyaku has chosen LifeSphere MultiVigilance as new case ...
ArisGlobal Receives Frost & Sullivan’s 2025 New Product Innovation Recognition for First-of-its-Kind Agentic AI in Pharmacovigilance
MedDRA Coding Agent celebrated for redefining PV through advanced automation, ...
ArisGlobal Announces Strategic Partnership with Cognizance Technologies to Accelerate Digital Transformation in Life Sciences and Government Sectors
Boston, Massachusetts, USA – October, 22, 2025 – ArisGlobal, an ...
Leading Japanese Pharmaceutical Organization Modernizes Global Safety Operations with LifeSphere®Â
Deployment of LifeSphere® Safety across three regions reinforces momentum for ...
